TEDD Competence Centre - Tissue Engineering for Drug Development and Substance Testing
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement) in the long term.
During this year’s TEDD Annual Meeting, we will explore the clinical applications of advanced cell culture models and highlight their potential in revolutionizing biomedical research and patient care. We will delve into their use in disease modelling, drug screening, personalized medicine, regenerative medicine, and other emerging areas. By examining the current state of the field and discussing recent advancements, we aim to shed light on the transformative potential of these models in clinical practice and pave the way for future developments in this exciting field.
Access only for TEDD members: contact firstname.lastname@example.org for password.
We welcome a new TEDD Partner!
Sino Biological is dedicated to providing the scientific community with high-quality recombinant protein and antibody reagents to promote life science research and drug discovery.
With the largest validated recombinant protein bank (6000+), a broad range of antigens are covered, including viral proteins, cytokines and growth factors, immune checkpoints, antigens for CAR-T cell therapy, Fc receptors, biomarker proteins, etc, as well as a comprehensive collection of high quality mono- and polyclonal antibodies.
Based on our rich experiences and expertise, several robust recombinant protein expression platforms and antibody discovery methods have been established for customized contracted research projects.
Yearly TEDD Partnership fee 2023 is CHF 500.
TEDD Partnership conditions:
- Two people from TEDD Partner organization can attend TEDD events free of charge. Subsequent people from this organization will receive a 50% discount for that event.
- TEDD Partnership period is from January to December of the given year.
- TEDD Partnership extends for the following year unless cancelled.
- TEDD Partner can cancel partnership latest on 30 November of the current year effective next year by sending us an email on email@example.com.
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.